Track topics on Twitter Track topics that are important to you
One of the causes of stroke, which can be treated, is narrowing of the carotid artery. Currently the only definite treatment option is surgery or endovascular treatment. All patients not qualified for or awaiting surgery are, therefore, left with pharmacological treatment and a yearly risk of stroke anywhere between 1% - 35% depending on the severity of the disease.
Lycopene is a carotenoid obtained from tomatoes. The anti-oxidative and antinflammatory properties of lycopene have been evaluated in prevention and treatment of cancer and cardiovascular disease. It has been shown to decrease inflammation and oxidative DNA damage. Further in vitro studies demonstrated a antiproliferative effect on smooth muscle cells. In clinical studies the levels of serum lycopene correlated with risk of subsequent myocardial infarction and stroke.
Ateronon is a compound with high bioavailability, potentially allowing for an early effect. 25 mg of lycopene daily could thus allow for an early effect of reducing plaque vulnerability and decreasing the risk of stroke as well as long term benefits on disease progression.
The investigators wish to assess whether the anti-oxidative properties of long-term lycopene supplementation could decrease the risk of stroke from the plaque (both early: 6 and 12 weeks of treatment and long-term: 6 and 12 months of treatment). The investigators will check this using magnetic resonance imaging of the plaque and transcranial Doppler ultrasonography for counting the number of blood clots in the brain arteries. Furthermore the investigators wish to examine the effect of long-term lycopene supplementation on blood cholesterol levels and lipid oxidation, blood markers of inflammation and injury of the inner lining of the arteries.
The study will be performed in a single center in the UK, double blind placebo controlled study.
Results from this pilot study will be used to design a bigger phase III clinical trial.
Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Carotid Atherosclerotic Disease
lycopene 25 mg/day, Placebo
Not yet recruiting
Cambridge University Hospitals NHS Foundation Trust
Published on BioPortfolio: 2014-08-27T03:14:38-0400
the purpose of this study was to evaluate that if lycopene, a potent antioxidant can be used in the treatment of oral lichen planus. this could be useful as lycopene has no reported side e...
Cerebrovascular disease is a leading cause of death and the leading cause of serious long-term disability. Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are alternative st...
The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System and Emboshield® Pro Embolic Protection Sy...
This is a Phase II, randomized, double-blind, placebo-controlled study of the effect of VIA-2291 on atherosclerotic vascular inflammation in patients with carotid stenosis scheduled for el...
The purpose of this study is to determine whether Ateronon, a nutritional supplement that contains lycopene from tomatoes has a favorable effect on carotid atherosclerosis, lipid levels, a...
Identification and treatment of the rupture prone atherosclerotic plaque remains a challenge for reducing the burden of cardiovascular disease. The interconnection of metabolic and inflammatory proces...
Carotid and coronary artery disease are two major atherosclerotic conditions that have shown an increased prevalence in the last three decades that is associated with high morbidity and mortality. Rec...
Although the relationship between atherosclerosis and cognitive impairment has been studied and replicated, whether cognitive deficits in RA can be attributed to atherosclerotic changes is not well un...
Our study examined whether osteocalcin contributed to identifying carotid intima-media thickness (C-IMT) over the atherosclerotic cardiovascular disease (ASCVD) risk score.
Every fifth ischemic stroke is caused by thromboembolism originating from an atherosclerotic carotid artery plaque. While prevention is the most cost-effective stroke therapy, antiplatelet and cholest...
Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp822-3)
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Damages to the CAROTID ARTERIES caused either by blunt force or penetrating trauma, such as CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damaged carotid arteries can lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and INTERNAL CAROTID ARTERY DISSECTION. (From Am J Forensic Med Pathol 1997, 18:251; J Trauma 1994, 37:473)
Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
Blood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...